Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (8): 1294-1298.doi: 10.16352/j.issn.1001-6325.2023.08.1294
• Mini Reviews • Previous Articles Next Articles
LI Xiang, LI Ye*
Received:2022-06-15
Revised:2022-11-13
Online:2023-08-05
Published:2023-07-26
Contact:
*liye918@gmail.com
CLC Number:
LI Xiang, LI Ye. Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease[J]. Basic & Clinical Medicine, 2023, 43(8): 1294-1298.
| [1] | Zhang C, Wang J, Ding S, et al. Relationship between lifestyle and metabolic factors and carotid atherosclerosis: a survey of 47,063 fatty and non-fatty liver patients in China[J]. Front Cardiovasc Med, 2022, 9:935185. doi: 10.3389/fcvm.2022.935185. |
| [2] | Lad A, Hunyadi J, Connolly J, et al. Antioxidant therapy significantly attenuates hepatotoxicity following low dose exposure to microcystin-LR in a murine model of diet-induced non-alcoholic fatty liver disease[J]. Antioxidants (Basel), 2022, 11:1625. doi: 10.3390/antiox11081625. |
| [3] | Chen TQ, Deng YF, Wang YY, et al. Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-κB signaling pathway[J]. Biochem Biophys Res Commun, 2022, 626:167-174. |
| [4] | Jiang JJ, Zhang GF, Zheng JY, et al. Targeting mitochondrial ROS-mediated ferroptosis by quercetin alleviates high-fat diet-induced hepatic lipotoxicity[J]. Front Pharmacol, 2022, 13:876550. doi: 10.3390/antiox11081625. |
| [5] | Bai J, Liu T, Tu B, et al. Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis[J]. Autophagy, 2023, 19:632-643. |
| [6] | Yan H, Zhuang M, Xu X, et al. Autophagy and its mediated mitochondrial quality control maintain pollen tube growth and male fertility in Arabidopsis[J]. Autophagy, 2023, 19:768-783. |
| [7] | Kannangara AR, Andersen JL. Mapping the proximity interactome of ATG9A reveals unexpected dynamics of ULK1 complex proteins[J]. Autophagy, 2022, 18:2754-2755. |
| [8] | 徐玲,马红艳,杨军,等. 高脂饮食通过p-AMPK/mTOR信号通路下调小鼠肝细胞自噬水平[J].基础医学与临床,2018,38:37-41. |
| [9] | Harada M, Hanada S, Toivola DM, et al. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation[J]. Hepatology, 2008, 47:2026-2035. |
| [10] | Zhou F, Ding M, Gu Y, et al. Aurantio-Obtusin attenuates non-alcoholic fatty liver disease through AMPK-mediated autophagy and fatty acid oxidation pathways[J]. Front Pharmacol, 2021, 12:826628. doi: 10.3389/fphar.2021.826628. |
| [11] | Zhang H, Lu J, Liu H, et al. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease[J]. Pharmacol Res, 2021, 174:105964. doi: 10.1016/j.phrs.2021.105964. |
| [12] | Luo T, Zheng Q, Shao L, et al. Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo[J]. Angew Chem Int Ed Engl, 2022, 4:e202206277. doi: 10.1002/anie.202206277. |
| [13] | Song X, Liu J, Kuang F, et al. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis[J]. Cell Rep, 2021, 34:108767. doi: 10.1016/j.celrep.2021.108767. |
| [14] | Li X, Wang TX, Huang X, et al. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liverlipotoxicity[J]. Liver Int, 2020, 40:1378-1394. |
| [15] | Loguercio C, De Girolamo V, de Sio I, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects[J]. J Hepatol, 2001, 35:568-574. |
| [16] | Qi J, Kim JW, Zhou Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice[J]. Am J Pathol, 2020, 190:68-81. |
| [17] | Yao C, Lan D, Li X, et al. Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis[J]. Microbes Infect, 2022, 17:105040. doi: 10.1016/j.micinf.2022.105040. |
| [18] | da Silva Lima N, Fondevila MF, Nóvoa E, et al. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function[J]. J Hepatol, 2022, 76:11-24. |
| [19] | Zhang R, Chu K, Zhao N, et al. Corilagin alleviates nonalcoholic fatty liver disease in high-fat diet-induced C57BL/6 mice by ameliorating oxidative stress and restor-ing autophagic Flux[J]. Front Pharmacol, 2019,10:1693. doi: 10.3389/fphar.2019.01693. |
| [20] | Kang R, Zhu S, Zeh HJ, et al. BECN1 is a new driver of ferroptosis[J]. Autophagy, 2018, 14:2173-2175. |
| [21] | Li J, Yuan J, Li Y, et al. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy[J]. Phytomedicine, 2022, 106:154411. doi: 10.1016/j.phymed.2022.154411. |
| [22] | Gao H, Bai Y, Jia Y, et al. Ferroptosis is a lysosomal cell death process[J]. Biochem Biophys Res Commun, 2018, 503:1550-1556. |
| [23] | Yi J, Wu S, Tan S, et al. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis[J]. Cell Death Discov, 2021, 7:374. doi: 10.1038/s41420-021-00768-7. |
| [24] | Zhang Z, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells[J]. Autophagy, 2020, 16:1482-1505. |
| [25] | Pennisi G, Enea M, Romero-Gomez M, et al. Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis[J]. Aliment Pharmacol Ther, 2022, 55:604-615. |
| [1] | ZHANG Yufeng, ZHANG Xinna, ZHOU Yanjiao. PHLPP2 variation is associated with prognosis as well as ferroptosis in patients of advanced lung adenocarcinoma harboring EGFR+TP53 co-mutations [J]. Basic & Clinical Medicine, 2026, 46(1): 103-108. |
| [2] | REN Jiuqiang, LI Jing, LI Zhuo, LIU Xuehui, LYU Xiang. A highly efficient SFFV promoter-driven mCherry-GFP-LC3B dual-fluorescence system for autophagy monitoring in erythroid cells [J]. Basic & Clinical Medicine, 2025, 45(7): 866-873. |
| [3] | YANG Yixuan, QIAN Xiaojing, LIU Zhenghui, HAN Daishu, CHEN Yongmei. Dynamic changes in autophagosome formation and lipid droplet accumulation during spermiogenesis in mice [J]. Basic & Clinical Medicine, 2025, 45(7): 851-857. |
| [4] | WEI Jianxin, FANG Yanle, LU Yubo, GAO Yuguang, LANG Xing, LI Jingtao, MA Xinsheng. Artesunate inhibits proliferation and promotes apoptosis and autophagy of nephroblastoma cell line SK-NEP-1 [J]. Basic & Clinical Medicine, 2025, 45(4): 493-498. |
| [5] | LOU Haijun, TONG Zhuoyun, ZHANG Zhenyu, Aheyerk·MAHESHATI, MENG·Menggen, WUDU Muli. Knockdown of DRAM2 inhibits the proliferation and migration of lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2025, 45(2): 197-202. |
| [6] | JIANG Hua, ZHANG He, JIANG Songsong. Sterol regulatory element binding protein 1 promotes proliferation and invision of prostate cancer cells [J]. Basic & Clinical Medicine, 2025, 45(2): 189-196. |
| [7] | LIU Tianna, LI Yang, DENG Yudi, WU Fuju. Progress on poly(C)-binding protein 1 in ferroptosis [J]. Basic & Clinical Medicine, 2025, 45(11): 1501-1505. |
| [8] | SUN Na, SONG Linlin, CHI Jinjin, ZHONG Lulu, WANG Zhensheng. Propofol improves bone metabolism in rat models with osteoporosis [J]. Basic & Clinical Medicine, 2025, 45(11): 1451-1456. |
| [9] | LI Wenhua, WANG Runlin, KANG Qianpeng, HUANG Mei, GUO Zhengguang, ZHANG Chunlin, HUANG Yongsheng. p97 inhibitor EerⅠ induces apoptosis and ferroptosis of gastric cancer cell line AGS [J]. Basic & Clinical Medicine, 2025, 45(11): 1401-1408. |
| [10] | NING Kangsheng, YUN Chao, LI Yi, Morigele. Research progress on mitophagy in the development and treatment of osteosarcoma [J]. Basic & Clinical Medicine, 2025, 45(10): 1377-1381. |
| [11] | FU Miao, LIU Peng, TIAN Wen, WANG Sha, YIN Xiaomei, LIU Hao, WANG Donghai. METTL3 regulates ferroptosis and malignant progression of cervical cancer cells through mediating TRPM7 methylation [J]. Basic & Clinical Medicine, 2025, 45(10): 1318-1325. |
| [12] | PANG Yunting, REN Xiaoshuang, BAO Han, MENG Fanqing, SHI Feng. Levosimendan attenuates suspension-reperfusion injury in isolated hearts of rat models [J]. Basic & Clinical Medicine, 2025, 45(1): 65-69. |
| [13] | XIAO Yanhong, JIANG Mingdong, LIN Yeyuan, RAN Can, LIANG Bo. Scutellarin inhibits proliferation and migration of human prostate cancer cell line PC-3 [J]. Basic & Clinical Medicine, 2024, 44(9): 1229-1235. |
| [14] | Zulipiya·ABULA, ZHAO Qiang, ZHANG Taimin, LI Tian. Marein alleviates high glucose-induced damage of rat myocardial cell line H9c2 [J]. Basic & Clinical Medicine, 2024, 44(9): 1269-1273. |
| [15] | ZHOU Changdong, LIN Yang, SUN Kai, TIAN Yuxin. Knockdown of lncRNA UCA1 reduces gemcitabine resistance of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2024, 44(8): 1113-1119. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||